The $101.4 million EIS has a 25.1% weight to Teva, which accounts for all of the ETF’s healthcare exposure. ISRA’s Teva weight is lighter at nearly 13%, but that ETF has the larger healthcare allocation at 31.2%. ISRA also features an almost 12% weight to Perrigo (NYSE: PRGO), the U.S.-listed shares of which are up nearly 5% in the past month. [Prowling Teva Could Lift Some Pharma ETFs]
Another developed market rising with the healthcare tide is Denmark. Danish stocks jumped 3.3% last month, bringing the year-to-date gain to 12.7%, according to S&P data. The iShares MSCI Denmark Capped ETF (BATS: EDEN) has surged 13.3% this year.
EDEN, which is home to $55.2 million in assets, allocates 37.2% of its weight to the healthcare sector. That is 1,250 basis points larger than EDEN’s second-largest weight, industrials. Novo Nordisk (NYSE: NVO), a stock that has climbed 29.1% this year, is EDEN’s largest holding at almost 24.7% of the ETF’s weight.
Market Vectors Israel ETF
